Medable pulls in $91m Series C

Palo Alto, California-based Medable Inc, a provider of software for managing clinical trials, has secured $91 million in Series C funding.

19 November 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles